fb tracking

Product Recalls: December 14, 2022 – January 18, 2023

Health Letter, February 2023

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.



Glycopyrrolate tablets, 1 mg, 50 or 100 tablets. Distributed by: Aurobindo Pharma USA, Inc. or Manufactured for: AvKARE. Lot #: 01422002A1, exp. date: 12/2023; Lot #: 01421078A3, exp. date: 09/2023.

Oxcarbazepine tablets; 600 mg; 100-, 500- or 1,000-count bottles. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: HAC1474A, exp. date: 03/2023; Lot #: HAC1503A, exp. date: 03/2023; Lot #: HAC1474B, exp. date 03/2023.

Quinapril tablets, 20 or 40 mg, 90-pack. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Lot #: G102929, exp. date: 04/2023; Lot #: G100533 or G100534, exp. date: 12/2022; Lot #: G203071, exp. date: 03/2024.

Rifampin capsules, 300 mg, 30-count bottle or blister card. Manufactured for: Lupin Pharmaceuticals. Manufactured by: Lupin Limited or Lupin Pharma. Lot #: A200171, exp. date: 12/2023; Lot #: J0599794-022322, exp. date: 02/28/2023; Lot #: J0621369-052622, exp. date: 06/30/2023.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.